# Rates DMBT1 ( Glycoprotein) in Sputum of CF Patients With Pseudomonas Aeruginosa

> **NCT02880111** · — · TERMINATED · sponsor: **University Hospital, Lille** · enrollment: 1 (actual)

## Conditions studied

- Malignant Brain Tumor

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02880111
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2016-03-23
- **Primary completion:** 2022-03
- **Final completion:** 2022-03
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** only one patient was included
- **Last updated:** 2022-10-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02880111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02880111, "Rates DMBT1 ( Glycoprotein) in Sputum of CF Patients With Pseudomonas Aeruginosa". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02880111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*